GlobeNewsWire
11 Jun 2026, 08:36 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Steatotic liver disease (SLD) is projected to affect approximately 1.8 billion people globally by 2050. — This establishes a massive potential total addressable market (TAM) for pharmaceutical companies developing liver disease treatments.
+0.40The World Health Organization (WHO) has adopted a resolution to reduce the burden of Noncommunicable Diseases, increasing global recognition of SLD. — WHO endorsement typically leads to increased government funding, improved diagnostic screening, and streamlined regulatory pathways.
+0.20Continue reading
6 related stories
Top 2 movers · tap to explore
Go deeper
You just saw which tickers this one story hits. A free account turns that into a standing screen: the movers delivered on schedule, before the chart catches up.
On this page · free
In the platform
Free account, 30 seconds. No credit card. Covers all 10 tickers this story moves.
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Screener bridge
Catch the names this kind of story moves — before the chart does.
Get the full NIS Momentum results every Friday at 4PM ET — free via email or Telegram.
GlobeNewsWire
10h ago
